Cytodyn Inc (CYDY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 05/31
(Values in U.S. thousands)
| 08-2025 | 05-2025 | 02-2025 | 11-2024 | 08-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -5,540 | 3,745 | 9,701 | 14,459 | 19,227 |
| Depreciation Amortization | 4 | 425 | 362 | 247 | 130 |
| Other Working Capital | 2,907 | -16,172 | -15,803 | -15,477 | -16,085 |
| Other Operating Activity | 179 | 3,237 | 2,638 | 2,625 | 2,168 |
| Operating Cash Flow | $-2,450 | $-8,765 | $-3,102 | $1,854 | $5,440 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 21 | 11,564 | 10,398 | 10,377 | 10,377 |
| Other Financing Activity | -142 | -710 | -710 | -710 | -710 |
| Financing Cash Flow | $-121 | $10,854 | $9,688 | $9,667 | $9,667 |
| Beginning Cash Position | 11,903 | 9,814 | 9,814 | 9,814 | 9,814 |
| End Cash Position | 9,332 | 11,903 | 16,400 | 21,335 | 24,921 |
| Net Cash Flow | $-2,571 | $2,089 | $6,586 | $11,521 | $15,107 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,450 | -8,765 | -3,102 | 1,854 | 5,440 |
| Free Cash Flow | -2,450 | -8,765 | -3,102 | 1,854 | 5,440 |